In January 2004, Verenium Corporation formed a collaboration with Bayer Animal Heath to develop and market novel vaccine products to prevent infectious diseases in fish.
Bayovac® SRS, which was commercialized under the collaboration with Bayer Animal Health, is a proprietary and novel subunit recombinant vaccine for farmed salmon. This vaccine product has demonstrated superior protection against salmon rickettsial septicemia (SRS). SRS is the major infectious disease in Chilean aquaculture, typically killing upwards of 20% of untreated farmed salmon, which represents the highest value per pound of all farmed animals. Bayovac® SRS received regulatory approval and recorded its first sales in September 2004 in Chile, which produces 40% of the world’s farmed salmon. This product is manufactured by Verenium and exclusively marketed and distributed by Bayer in Chile.
"Protect animals, benefit people" is the mission at Bayer Animal Health. Bayer has attained this leadership position by continuously researching and developing new products for animal health and pest control since 1919. For further information, visit www.animalhealth.bayerhealthcare.com.
